HK1006420A1 - Analgesic agent and its use - Google Patents

Analgesic agent and its use

Info

Publication number
HK1006420A1
HK1006420A1 HK98105740A HK98105740A HK1006420A1 HK 1006420 A1 HK1006420 A1 HK 1006420A1 HK 98105740 A HK98105740 A HK 98105740A HK 98105740 A HK98105740 A HK 98105740A HK 1006420 A1 HK1006420 A1 HK 1006420A1
Authority
HK
Hong Kong
Prior art keywords
analgesic agent
analgesic
agent
levobupivacaine
anaesthetic
Prior art date
Application number
HK98105740A
Other languages
English (en)
Inventor
Hazel J Bardsley
Robert W Gristwood
Original Assignee
Chiroscience Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26303667&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1006420(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB939321061A external-priority patent/GB9321061D0/en
Priority claimed from GB9408014A external-priority patent/GB9408014D0/en
Application filed by Chiroscience Ltd filed Critical Chiroscience Ltd
Publication of HK1006420A1 publication Critical patent/HK1006420A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK98105740A 1993-10-13 1998-06-19 Analgesic agent and its use HK1006420A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB939321061A GB9321061D0 (en) 1993-10-13 1993-10-13 Analgestic agent and its use
GB9408014A GB9408014D0 (en) 1994-04-22 1994-04-22 Analgesic agent and its use
PCT/GB1994/002249 WO1995010277A1 (en) 1993-10-13 1994-10-13 Analgesic agent and its use

Publications (1)

Publication Number Publication Date
HK1006420A1 true HK1006420A1 (en) 1999-02-26

Family

ID=26303667

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98105740A HK1006420A1 (en) 1993-10-13 1998-06-19 Analgesic agent and its use

Country Status (15)

Country Link
US (1) US5708011A (da)
EP (2) EP0727210B1 (da)
JP (2) JPH09503778A (da)
KR (1) KR100365979B1 (da)
CN (1) CN1074920C (da)
AT (2) ATE150643T1 (da)
AU (1) AU694453B2 (da)
DE (2) DE69429536T2 (da)
DK (2) DK0727210T3 (da)
ES (2) ES2101578T3 (da)
GR (1) GR3023289T3 (da)
HK (1) HK1006420A1 (da)
NO (1) NO308508B1 (da)
PT (1) PT727210E (da)
WO (1) WO1995010277A1 (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9321061D0 (en) * 1993-10-13 1993-12-01 Chiroscience Ltd Analgestic agent and its use
GB9507677D0 (en) * 1995-04-13 1995-05-31 Chiroscience Ltd Pharmaceutical formulation and dose
JPH11503444A (ja) * 1995-04-13 1999-03-26 カイロサイエンス・リミテッド レボブピバカインおよびその妊婦麻酔剤としての使用
GB9704352D0 (en) * 1997-03-03 1997-04-23 Chiroscience Ltd Levobupivacaine and its use
GB9704351D0 (en) * 1997-03-03 1997-04-23 Chiroscience Ltd Levobupivacaine and its use
GB9704370D0 (en) * 1997-03-03 1997-04-23 Chiroscience Ltd Levobupivacaine and its use
JP2001510794A (ja) * 1997-07-21 2001-08-07 ダーウィン・ディスカバリー・リミテッド レボブピバカインとその使用
DE69814394T2 (de) * 1997-07-22 2004-03-11 Darwin Discovery Ltd., Slough Verwendung von levobupivacain
ATE535232T1 (de) 1997-09-18 2011-12-15 Pacira Pharmaceuticals Inc Retardierte freisetzung liposomaler anesthetischer zusammensetzungen
IL135989A0 (en) * 1997-11-14 2001-05-20 Skyepharma Inc Processes for the production of multivesicular liposomes
PT1032390E (pt) * 1997-11-19 2004-04-30 Darwin Discovery Ltd Formulacao anestesica
US6277413B1 (en) 1998-07-17 2001-08-21 Skyepharma, Inc. Biodegradable compositions for the controlled release of encapsulated substances
BR0002246A (pt) * 2000-04-06 2003-04-15 Cristalia Prod Quimicos Farm Processo de obtenção dos enantiÈmeros da bupivacaìna racêmica, processo de obtenção de composições farmacêuticas a base de levobupivacaìna: composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis e utilização das composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis
EP1395243A2 (en) * 2001-05-31 2004-03-10 SkyePharma Inc. Encapsulation of nanosuspensions in liposomes and microspheres
KR20040058101A (ko) * 2001-11-14 2004-07-03 알자 코포레이션 카테터 주입가능한 데포 조성물 및 그의 용도
US20070196415A1 (en) * 2002-11-14 2007-08-23 Guohua Chen Depot compositions with multiple drug release rate controls and uses thereof
WO2003041684A2 (en) * 2001-11-14 2003-05-22 Alza Corporation Injectable depot compositions and uses thereof
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
CN101057824A (zh) * 2002-07-31 2007-10-24 阿尔萨公司 可注射的多模式聚合物储库组合物以及其用途
US8252303B2 (en) * 2002-07-31 2012-08-28 Durect Corporation Injectable depot compositions and uses thereof
US20060142234A1 (en) * 2004-12-23 2006-06-29 Guohua Chen Injectable non-aqueous suspension
CN102307895A (zh) * 2008-12-04 2012-01-04 里兰斯坦福初级大学理事会 用于治疗或预防麻醉药停药症状的方法和组合物
US20160303242A1 (en) 2013-12-09 2016-10-20 Durect Corporation Pharmaceutically Active Agent Complexes, Polymer Complexes, and Compositions and Methods Involving the Same
CN106214670B (zh) * 2016-07-25 2020-12-29 上海璃道医药科技有限公司 酰胺类药物的用途
JP2023515918A (ja) 2020-01-13 2023-04-17 デュレクト コーポレーション 不純物が低減された徐放性薬物送達システム及び関連の方法
US11033495B1 (en) 2021-01-22 2021-06-15 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11278494B1 (en) 2021-01-22 2022-03-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11357727B1 (en) 2021-01-22 2022-06-14 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695576A (en) * 1984-07-09 1987-09-22 Astra Lake Medel Aktiebolag L-N-n-propylpipecolic acid-2,6-xylidide
JPH11503444A (ja) * 1995-04-13 1999-03-26 カイロサイエンス・リミテッド レボブピバカインおよびその妊婦麻酔剤としての使用

Also Published As

Publication number Publication date
NO961479D0 (no) 1996-04-12
AU7859494A (en) 1995-05-04
US5708011A (en) 1998-01-13
DE69429536D1 (de) 2002-01-31
DE69402330T2 (de) 1997-07-03
DK0727210T3 (da) 2002-04-15
CN1074920C (zh) 2001-11-21
ATE210982T1 (de) 2002-01-15
DE69402330D1 (de) 1997-04-30
DK0723445T3 (da) 1997-10-06
EP0723445A1 (en) 1996-07-31
EP0727210A2 (en) 1996-08-21
ATE150643T1 (de) 1997-04-15
WO1995010277A1 (en) 1995-04-20
JP2006213736A (ja) 2006-08-17
CN1133010A (zh) 1996-10-09
NO308508B1 (no) 2000-09-25
ES2101578T3 (es) 1997-07-01
AU694453B2 (en) 1998-07-23
JPH09503778A (ja) 1997-04-15
EP0723445B1 (en) 1997-03-26
KR100365979B1 (ko) 2003-07-22
PT727210E (pt) 2002-06-28
EP0727210A3 (en) 1998-03-04
NO961479L (no) 1996-06-11
ES2170179T3 (es) 2002-08-01
EP0727210B1 (en) 2001-12-19
GR3023289T3 (en) 1997-07-30
DE69429536T2 (de) 2002-06-20

Similar Documents

Publication Publication Date Title
GR3023289T3 (en) Analgesic agent and its use
AR244556A1 (es) Dispositivo para inyecciones, de uso medico y veterinario.
AU3008092A (en) Novel use of modafinil
AU1310395A (en) A device for the supply of oxygen and/or other gases to a patient
HK1001374A1 (en) Nimesulide for external use
AU635074B2 (en) S(+)-ibuprofen-l-amino acid and s(+)-ibuprofen-d-amino acid as onset hastened enhanced analgesics
KR970009885B1 (en) 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide as an analgesic and anti-inflammtory agent
AU4238693A (en) Dopamine and noradrenergic reuptake inhibitors in treatment of schizophrenia
GB9704351D0 (en) Levobupivacaine and its use
AP9300555A0 (en) Therapeutic agent and its use
ZA934021B (en) Treatment of bovine mastitis
ITRM930565A0 (it) Procedimento e dispositivo per l'introduzione di sviluppi in stampi per imbutitura.
NO974708L (no) Levobupivacain og dets anvendelse som anestetikum i gravide kvinner
EP0356945A3 (de) Verwendung von Plasminogen-Aktivator-Inhibitor (PAI-2) zur Immunsuppression
MY111755A (en) Use of 4'-iodo-4'- deoxydoxorubicin for the treatment of amyloidosis.
AU5565890A (en) An acaricidal composition and use thereof in disinfesting treatments
HUT68292A (en) Polymer mixture and use thereof
ZA918516B (en) A corrosion inhibitor for use in coating formulations comprising synergistic combinations of a calcium borate and an amino carboxylate
AU5183098A (en) Analgesic agent and its use
IT9035909V0 (it) Dispositivo per l'erogazione di ossigeno terapeutico portatile per l'emergenza e utilizzabile anche come aerosol con innesto di fiala con essenze vegetali
DE9313063U1 (de) Spiel- und Therapiegerät
IT1265055B1 (it) Uso della 4'-desossi-4'-iododoxorubicina per il trattamento della al amiloidosi
GB9321921D0 (en) An immobilising device applicable to people and animals
ZA948501B (en) Heteroarylpiperidines pyrrolidines and piperazines and their use as antipsychotics and analgetics
AU7801594A (en) Boronated metalloporphyrins and therapeutic methods

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20141012